Atlas Trials

Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2

RecordFirmDate
ATHENA: Natural History of Disease Study in Alport Syndrome Patients (NCT02136862)Genzyme, a Sanofi Company2014-09-04

Track Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2 automatically

Every clearance here is in the API, with alerts when new ones post.